The Washington University COVID-19 biorepository that was jointly sponsored by The Foundation for Barnes-Jewish Hospital, the Siteman Cancer Center, and the ICTS, has been an incredible success. Use of these samples has diminished substantially over the past two years and all remaining samples are being distributed to final users by the Tissue Procurement Core. The resource will no longer be available to the Washington University community in the future. Some remaining samples, if not requested, may be discarded.

Any individuals interested in using these samples prior to the final distributions from the biorepository must contact Brian Goetz in the Tissue Procurement Core by June 1st, 2024.

Funding Acknowledgement for COVID-19 Biorepository

Any publication that used samples from the Washington University COVID-19 biorepository must cite the following support:

“This study utilized samples obtained from the Washington University School of Medicine’s COVID-19 biorepository, which is supported by: The Foundation for Barnes-Jewish Hospital; the Siteman Cancer Center grant P30 CA091842 from the National Cancer Institute of the National Institutes of Health; and the Washington University Institute of Clinical and Translational Sciences grant UL1TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the view of the NIH.”